B. Wiro, F. Stam, R. N. Aversa, J. P. Kumar, and . Jansen, Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy. Value Health, pp.830-871, 2008.

C. Beck-sague and W. Jarvis, Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990, Journal of Infectious Diseases, vol.167, issue.5, pp.1247-51, 1980.
DOI : 10.1093/infdis/167.5.1247

A. Gullo, Invasive Fungal Infections, Drugs, vol.21, issue.6, pp.65-73, 2009.
DOI : 10.2165/11315530-000000000-00000

A. Awasthi, A. Jain, S. Awasthi, A. Ambast, K. Singh et al., Epidemiology and microbiology of nosocomial pediatric candidemia at a northern indian tertiary care hospital. Mycopathologia, 2011.

A. Berthe, A. Duclos, I. Ray-coquard, C. Colin, and N. Bleyzac, ??valuation de l???adh??sion au r??f??rentiel Afssaps sur les antifongiques, en h??mato-oncologie p??diatrique, M??decine et Maladies Infectieuses, vol.41, issue.1, pp.25-32, 2011.
DOI : 10.1016/j.medmal.2010.09.012

Z. Te, K. Heydon, J. Chu, T. Walsh, and W. Steinbach, Epidemiology, outomes, and costs of invasive aspergillosis in immunocompromised children in the United States, Pediatrics, vol.117, issue.4, pp.711-717, 2006.

C. Lass-flörl, Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy. Expert Rev Anti Infcet Ther, Feb, vol.8, issue.2, pp.127-162, 2010.

W. Steinbach, Epidemiology of invasive fungal infections in neonates and children, Clinical Microbiology and Infection, vol.16, issue.9
DOI : 10.1111/j.1469-0691.2010.03288.x

M. Vogeser, A. Wanders, A. Haas, and G. Ruckdeschel, A Four-Year Review of Fatal Aspergillosis, European Journal of Clinical Microbiology & Infectious Diseases, vol.18, issue.1, pp.42-47, 1999.
DOI : 10.1007/s100960050224

K. Vandewoude, S. Blot, D. Benoit, P. Depuydt, D. Vogelaers et al., INVASIVE ASPERGILLOSIS IN CRITICALLY ILL PATIENTS: ANALYSIS OF RISK FACTORS FOR ACQUISITION AND MORTALITY, Acta Clinica Belgica, vol.26, issue.376, pp.251-258, 2004.
DOI : 10.1016/j.jhin.2004.01.006

J. Perlroth, B. Choi, and B. Spellberg, Nosocomial fungal infections: epidemiology, diagnosis, and treatment, Medical Mycology, vol.45, issue.4, pp.321-367, 2007.
DOI : 10.1080/13693780701218689

P. Massanet, P. Corne, and M. Conseil, Traitements antifongiques des candid??mies chez les patients non neutrop??niques??: ??valuation des pratiques en r??animation, M??decine et Maladies Infectieuses, vol.40, issue.11, pp.644-653, 2010.
DOI : 10.1016/j.medmal.2010.06.007

M. Mor, G. Gilad, L. Kornreich, S. Fisher, I. Yaniv et al., Invasive fungal infections in pediatric oncology. Pediatr Blood Cancer, Jul1, vol.56, issue.7, pp.1092-1099, 2011.

H. Boucher, A. Groll, C. Chiou, and T. Walsh, Newer Systemic Antifungal Agents, Drugs, vol.49, issue.3, pp.1997-2020, 2004.
DOI : 10.2165/00003495-200464180-00001

C. Hennen, Pharmacoeconomic evaluations of antifungal therapies, Curr Med Res Opin, vol.25, issue.7, pp.1751-1759, 2009.

S. Jean and P. Hsueh, Antimicrobial Drug Resistance in Taiwan, Journal of the Formosan Medical Association, vol.110, issue.1, pp.4-13, 2011.
DOI : 10.1016/S0929-6646(11)60002-8

C. Lass-flörl, The changing face of epidemiology of invasive fungal disease in Europe, Mycoses, vol.11, issue.3, pp.197-205, 2009.
DOI : 10.1111/j.1439-0507.2009.01691.x

G. Alangaden, Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention, Infectious Disease Clinics of North America, vol.25, issue.1, pp.201-226, 2011.
DOI : 10.1016/j.idc.2010.11.003

I. Ruiz-camps, J. Aguado, and B. Almirante, Guidelines for the prevention of invasive mould disease caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) Clin Microbiol Infcet, 2011.

A. Tobar, O. Silva, C. Olivares, G. Gaete, and N. Luppi, Candidiasis invasoras en el paciente cr??tico adulto, Revista chilena de infectolog??a, vol.28, issue.1, pp.41-50, 2011.
DOI : 10.4067/S0716-10182011000100008

I. Ruiz-camps, Tratamiento combinado de la aspergilosis invasora. ??Una oportunidad para micafungina?, Enfermedades Infecciosas y Microbiolog??a Cl??nica, vol.29, issue.2, pp.38-42, 2011.
DOI : 10.1016/S0213-005X(11)70008-8

D. Champs-bro, B. Leroy-cotteau, A. Mazingue, and F. , Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology, Journal of Clinical Pharmacy and Therapeutics, vol.8, issue.Suppl. 1, pp.152-60, 2011.
DOI : 10.1111/j.1365-2710.2010.01166.x

. Afssaps, Référentiel national de bon usage hors GHS antifongiques http://www.afssaps.fr/Dossiersthematiques/Tarification-a-l-activite-T2A-des medicaments, p.2, 2008.

R. Herbrecht, U. Flückiger, B. Gachot, P. Ribaud, A. Thiebaut et al., Antifungal therapy in leukemia patients, Update of the ECIL 1 and ECIL 2 Guidelines. Third European conference on infections in leukemia, 2009.

O. Marchetti, C. Cordonnier, and C. T. , Empirical antifungal therapy 2009 Update of the ECIL 1 and ECIL 2 Guidelines, Third European conference on infections in leukemia, 2009.

J. Maertens, P. Frère, C. Lass-flörl, W. Heinz, and O. Cornely, Antifungal prophylaxis in leukemia patients 2009 Update of the ECIL 1 and ECIL 2 Guidelines, Third European conference on infections in leukemia, 2009.

T. Walsh, T. Anaissie, and D. Denning, Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.46, issue.3, p.46, 2008.
DOI : 10.1086/525258

P. Pappas, C. Kauffman, and D. Andes, Clinical Practice Guidelines for the Management of Candidiasis, Update by the Infectious Diseases Society of America. CID, p.48, 2009.

P. Pavese, Z. Ouachi, and J. Vittoz, Revue de??pertinence des??prescriptions des??nouveaux antifongiques syst??miques dans??un??h??pital universitaire, M??decine et Maladies Infectieuses, vol.37, pp.223-231, 2007.
DOI : 10.1016/j.medmal.2007.05.009

O. Leroy, J. Mira, and P. Montravers, Candidoses invasives en r??animation??: analyse des traitements antifongiques au cours de l???enqu??te fran??aise AmarCand, Annales Fran??aises d'Anesth??sie et de R??animation, vol.27, issue.12, pp.999-1007, 2008.
DOI : 10.1016/j.annfar.2008.10.004

M. Jones, S. Greenfield, and C. Bradley, Prescribing new drugs: qualitative study of influences on consultants and general practitioners, BMJ, vol.323, issue.7309, pp.378-81, 2001.
DOI : 10.1136/bmj.323.7309.378

M. Cabana, C. Rand, N. Powe, A. Wu, M. Wilson et al., Why Don't Physicians Follow Clinical Practice Guidelines? A Framework for Improvement, Pediatric Research, vol.45, issue.4, Part 2 of 2, pp.1458-65, 1999.
DOI : 10.1203/00006450-199904020-00719

D. Grande, D. Frosch, A. Perkins, and B. Kahn, Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences, Archives of Internal Medicine, vol.169, issue.9, pp.887-893, 2009.
DOI : 10.1001/archinternmed.2009.64

K. Austad, J. Avorn, and A. Kesselheim, Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review, PLoS Medicine, vol.23, issue.5, 2011.
DOI : 10.1371/journal.pmed.1001037.s002

F. Stripeli, M. Tsolia, T. Ch, V. Papaevangelou, E. Vlachos et al., Successful medical treatment of Candida endocarditis with liposomal amphotericin B without surgical intervention, European Journal of Pediatrics, vol.119, issue.3, pp.469-470, 2008.
DOI : 10.1007/s00431-007-0498-8

D. Yilmaz, C. Balkan, M. Akin, B. Karapinar, and K. Kavakli, A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections, Mycoses, vol.48, issue.3, pp.234-276, 2011.
DOI : 10.1111/j.1439-0507.2009.01808.x

C. Mihu, C. Kassis, E. Ramos, Y. Jiang, R. Hachem et al., Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients ? Cancer, pp.5290-5296, 2010.

D. Caillot, A. Thiébaut, and R. Herbrecht, Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies, Cancer, vol.187, issue.12, pp.2740-2746, 2007.
DOI : 10.1002/cncr.23109

F. Saillour-glénisson, S. Domecq, M. Pouchadon, B. Jacques, and M. Sibé, Analyse qualitative et quantitative des déterminants à l'application de recommandations